Direct signal transduction via functional interferon-αβ receptors in CD34+ hematopoietic stem cells

Leukemia

Volumn 16, Issue 6, 2002, Pages 1135-1142

  Giron Michel, J ^b   Weill, D ^a   Bailly, G ^a   Legras, S ^b   Nardeux, P C ^a   Azzarone, B ^b   Tovey, M G ^a   Eid, P ^a  

^a CNRS   (France)

^b HÔPITAL PAUL BROUSSE   (France)

Author keywords

Anti IFNAR1; CD34+ cells; Interferon receptor

Indexed keywords

ALPHA INTERFERON RECEPTOR; BETA INTERFERON RECEPTOR; CD34 ANTIGEN; CYTOKINE; GROWTH FACTOR; INTERFERON RECEPTOR; JANUS KINASE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT ALPHA INTERFERON; STAT1 PROTEIN; STAT2 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ACCESSORY CELL; ARTICLE; BINDING SITE; BURST FORMING UNIT E; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; COLONY FORMING UNIT GM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; ISOTOPE LABELING; NEWBORN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PURIFICATION; SCATCHARD PLOT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 85014152025     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402492     Document Type: Article

References (46)

1. Differential expression of granulocyte-macrophage colony-stimulating factor and IL-3 receptor subunits on human CD34+ cells and leukemic cell lines
2. Cytokine receptor expression on hematopoietic stem and progenitor cells
3. Numerous growth factors, cytokines, and chemokines are secreted by human CD34+ cells, myeloblasts, erythroblasts and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner
4. Interferons and their actions
5. How cells respond to interferons
6. UK Medical Research Council randomised, multicentre trial of interferon- alpha for chronic myeloid leukaemia: Improved survival irrespective of cytogenetic response
7. Cytogenetic conversion in a case of polycythaemia vera treated with interferon-alpha
8. Long-term follow-up results of alpha interferon therapy in chronic myelogenous leukemia at MD Anderson Cancer Center
9. The essential role of endogenous IFN alpha/beta in the anti-metastatic action of sensitized T lymphocytes in mice injected with Friend erythroleukemia cells
10. Interferon-alpha-induced apoptosis in human erythroid progenitors
11. Gamma interferon (IFN gamma) and IFN alpha/beta suppress murine myeloid colony formation (CFU-C)N: Magnitude of suppression is dependent upon level of colony-stimulating factor (CSF)
12. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells
13. Alpha-interferon: Differential suppression of colony growth from human erythroid, myeloid, and megakaryocytic hematopoietic progenitor cells
14. Effects of recombinant alpha and gamma interferons on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM) from patients with myelofibrosis with myeloid metaplasia
15. Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells
16. Recombinant interferon-alpha-2C in chronic myelogenous leukaemia: Relationship of sensitivity of committed haematopoietic precursor cells in vitro (BFU-E, CFU-GM, CFU-Meg) and clinical response
17. All-trans retinoic acid potentiates the inhibitory effects of interferon alpha on chronic myeloid leukemia progenitors in vitro
18. Interferon-alpha overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells
19. Regulation of cytokine expression by interferon-alpha in human bone marrow stromal cells: Inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist
20. Inhibition of human erythroid colony-forming units by interferons alpha and beta: Differing mechanisms despite shared receptor
21. Influence of interferon-alpha on cytokine expression by the bone marrow microenvironment-impact on treatment of myeloproliferative disorders
22. A protein tyrosine kinase in the interferon alpha/beta signaling pathway
23. Alpha and beta interferons and their receptor and their friends and relations
24. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
25. Jaks and Stats in signaling by the cytokine receptor superfamily
26. Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex
27. A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor
28. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons
29. Characterization of a domain of a human type I interferon receptor protein involved in ligand binding
30. Raising antibodies to human leukocyte interferon
31. Prolonged allograft survival in cynomolgus monkeys treated with a monoclonal antibody to the human type I interferon receptor and low doses of cyclosporine
32. Interferon alpha in the therapy of CML
33. Predicting complete cytogenetic response in chronic myelogenous leukemia patients treated with recombinant interferon alpha
34. Current aspects of drug therapy in Philadelphia-positive CML: Correlation of tumor burden with survival
35. Effect of IFN-alpha on normal human hematopoiesis: An immunohistochemical and morphometric study on trephine biopsy specimens
36. Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver
37. Quantitative analysis of interferon alpha/beta receptor mRNA in the liver of patients with chronic hepatitis C: Correlation with serum hepatitis C virus RNA levels and response to treatment with interferon
38. Expression of interferon alpha/beta receptor in the liver of chronic hepatitis C patients
39. Changes in signal transduction downstream from the granulocyte-macrophage colony-stimulating factor receptor during differentiation of primary hemopoietic cells
40. CXC chemokine receptor 3 expression on CD34(+) hematopoietic progenitors from human cord blood induced by granulocyte-macrophage colony-stimulating factor: Chemotaxis and adhesion induced by its protein 10 and monokine induced by interferon gamma
41. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin
42. Characterization of specific functional receptors for HulFN-alpha on a human megakaryocytic cell line (Dami): Expression related to differentiation
43. Post-translational up-regulation of the cell surface-associated alpha component of the human type I interferon receptor during differentiation of peripheral blood monocytes: Role in the biological response to type I interferon
44. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells
45. Cytokine signaling through nonreceptor protein tyrosine kinases